Susquehanna International Group LLP trimmed its position in shares of Innospec Inc. (NASDAQ:IOSP – Free Report) by 65.5% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 3,615 shares of the specialty chemicals company’s stock after selling 6,877 shares during the quarter. Susquehanna International Group LLP’s holdings in Innospec were worth $294,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the business. Meeder Asset Management Inc. purchased a new position in Innospec during the 2nd quarter valued at about $36,000. EverSource Wealth Advisors LLC lifted its holdings in Innospec by 1,159.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock worth $44,000 after buying an additional 487 shares during the period. Hantz Financial Services Inc. grew its position in shares of Innospec by 271.0% in the 4th quarter. Hantz Financial Services Inc. now owns 575 shares of the specialty chemicals company’s stock worth $44,000 after buying an additional 420 shares during the last quarter. Danske Bank A S purchased a new position in shares of Innospec during the third quarter valued at approximately $46,000. Finally, Caitong International Asset Management Co. Ltd raised its holdings in shares of Innospec by 316.4% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 662 shares of the specialty chemicals company’s stock valued at $51,000 after acquiring an additional 503 shares in the last quarter. 96.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages recently commented on IOSP. Seaport Research Partners reaffirmed a “buy” rating and issued a $110.00 price target on shares of Innospec in a research note on Thursday, August 6th. Weiss Ratings upgraded shares of Innospec from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 6th. Finally, Wall Street Zen raised shares of Innospec from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.
Innospec Stock Performance
Shares of NASDAQ:IOSP opened at $92.61 on Wednesday. The firm has a market capitalization of $2.28 billion, a P/E ratio of 18.90, a P/E/G ratio of 2.49 and a beta of 0.93. The stock has a 50 day moving average price of $87.58 and a 200-day moving average price of $81.02. Innospec Inc. has a 52-week low of $65.51 and a 52-week high of $96.68.
Innospec (NASDAQ:IOSP – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The specialty chemicals company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.22. The company had revenue of $491.40 million for the quarter, compared to analyst estimates of $457.25 million. Innospec had a return on equity of 9.22% and a net margin of 6.60%.The firm’s revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the company posted $1.26 earnings per share. On average, equities analysts forecast that Innospec Inc. will post 5.03 EPS for the current fiscal year.
Innospec Company Profile
Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
Recommended Stories
- Five stocks we like better than Innospec
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP – Free Report).
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
